{"id":3983,"date":"2020-09-15T13:52:33","date_gmt":"2020-09-15T12:52:33","guid":{"rendered":"https:\/\/www.ab-science.com\/accueil\/"},"modified":"2025-05-21T11:28:26","modified_gmt":"2025-05-21T10:28:26","slug":"accueil","status":"publish","type":"page","link":"https:\/\/www.ab-science.com\/fr\/","title":{"rendered":"Accueil"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css=\u00a0\u00bb.vc_custom_1601559325217{margin-top: 0px !important;padding-top: 0px !important;}\u00a0\u00bb][vc_column]\n\t\t\t\t<p class=\"rs-p-wp-fix\"><\/p>\n\t\t\t\t<sr7-module data-alias=\"slider-1\" data-id=\"2\" id=\"SR7_2_1\" data-version=\"6.7.58\">\n\t\t\t\t\t<sr7-adjuster><\/sr7-adjuster>\n\t\t\t\t\t<sr7-content>\n\t\t\t\t\t\t<sr7-slide id=\"SR7_2_1-1\" data-key=\"1\">\n\t\t\t\t\t\t\t<sr7-bg id=\"SR7_2_1-1-slidebg\" class=\"sr7-layer\"><noscript><img decoding=\"async\" src=\"https:\/\/www.ab-science.com\/wp-content\/uploads\/2023\/02\/water-molecules-science-or-medical-background-wit-2022-12-16-21-47-06-utc-scaled.jpg\" alt=\"\" title=\"Water molecules. Science or medical background with molecules and atoms. 3d render\"><\/noscript><\/sr7-bg>\n\t\t\t\t\t\t\t<sr7-txt id=\"SR7_2_1-1-0\" class=\"sr7-layer\">D\u00e9velopper des th\u00e9rapies innovantes dans des maladies \u00e0 fort besoin m\u00e9dical<\/sr7-txt>\n\t\t\t\t\t\t<\/sr7-slide>\n\t\t\t\t\t\t<sr7-slide id=\"SR7_2_1-3\" data-key=\"3\">\n\t\t\t\t\t\t<\/sr7-slide>\n\t\t\t\t\t<\/sr7-content>\n\t\t\t\t<\/sr7-module>\n\t\t\t\t<script>\n\t\t\t\t\twindow.SR7 ??={};SR7.PMH ??={}; SR7.PMH[\"SR7_2_1\"] = {cn:100,state:false,fn: function() { if (window._tpt!==undefined && window._tpt.prepareModuleHeight !== undefined) {  _tpt.prepareModuleHeight({id:\"SR7_2_1\",el:[620],type:'standard',shdw:'0',gh:[620],gw:[1240],vpt:['-200px'],size:{fullWidth:true, fullHeight:false},mh:'0',onh:0,onw:0,bg:{color:'transparent'},plType:'0',plColor:'#ffffff'});   SR7.PMH[\"SR7_2_1\"].state=true;} else if(SR7.PMH[\"SR7_2_1\"].cn-->0)\tsetTimeout( SR7.PMH[\"SR7_2_1\"].fn,19);}};SR7.PMH[\"SR7_2_1\" ].fn();\n\t\t\t\t<\/script>\n[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-6a67051b99d8a\" data-id=\"6a67051b99d8a\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"dt-fancy-separator h2-size accent-title-color accent-border-color\" style=\"width: 100%;\"><div class=\"dt-fancy-title\"><span class=\"separator-holder separator-left\"><\/span>Derni\u00e8res actualit\u00e9s<span class=\"separator-holder separator-right\"><\/span><\/div><\/div><div class=\"ult-spacer spacer-6a67051b99e1f\" data-id=\"6a67051b99e1f\" data-height=\"20\" data-height-mobile=\"10\" data-height-tab=\"20\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"10\" style=\"clear:both;display:block;\"><\/div><style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article {\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article:first-of-type {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.classic-layout-list.mode-list .post-entry-content {\n  width: calc(100% - );\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.classic-layout-list.mode-list .no-img .post-entry-content {\n  width: 100%;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .filter-bg-decoration .filter-categories a.act {\n  color: #fff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap {\n  padding: 0px 0px 0px 0px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.enable-bg-rollover .post-thumbnail-rollover:after {\n  background: -webkit-linear-gradient();\n  background: linear-gradient();\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  width: 44px;\n  height: 44px;\n  line-height: 44px;\n  border-radius: 100px;\n  margin: -22px 0 0 -22px;\n  border-width: 0px;\n  color: #ffffff;\n}\n.bottom-overlap-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin-top: -72px;\n}\n.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico,\n.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin: 0 0 10px;\n}\n.content-align-center.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico,\n.content-align-center.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin: 0 auto 10px;\n}\n.dt-icon-bg-on.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  background: rgba(255,255,255,0.3);\n  box-shadow: none;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico:before {\n  font-size: 32px;\n  line-height: 44px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico:before {\n  color: #ffffff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-title,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.owl-carousel .entry-title {\n  margin-bottom: 5px;\n  font-weight: bold;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-meta {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .portfolio-categories {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-excerpt {\n  margin-bottom: 5px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.centered-layout-list) .post-entry-content {\n  padding: 25px 30px 30px 30px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.centered-layout-list):not(.content-bg-on):not(.mode-list) .no-img .post-entry-content {\n  padding: 0;\n}\n@media screen and (max-width: ) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 article {\n    -ms-flex-flow: column nowrap;\n    flex-flow: column nowrap;\n    margin-top: 20px;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on article {\n    border: none;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.content-bg-on.centered-layout-list article {\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.blog-shortcode.dividers-on article,\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article {\n    margin-top: 20px;\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.blog-shortcode.dividers-on article:first-of-type,\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article:first-of-type {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content {\n    width: 100%;\n    margin: 0;\n    top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content:after {\n    display: none;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .project-even .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-thumbnail-wrap {\n    -ms-flex-order: 0;\n    order: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-entry-title-content {\n    -ms-flex-order: 1;\n    order: 1;\n    width: 100%;\n    padding: 20px 20px 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-entry-content {\n    -ms-flex-order: 2;\n    order: 2;\n    padding-top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .fancy-categories {\n    top: 10px;\n    left: 10px;\n    bottom: auto;\n    right: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .fancy-date a {\n    top: 10px;\n    right: 10px;\n    left: auto;\n    bottom: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content {\n    padding: 20px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-title {\n    margin: 3px 0 5px;\n    font-size: 20px;\n    line-height: 26px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-meta {\n    margin: 5px 0 5px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-excerpt {\n    margin: 15px 0 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-details {\n    margin: 5px 0 10px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-details.details-type-link {\n    margin-bottom: 2px;\n  }\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid {\n  grid-row-gap: 30px;\n  grid-column-gap: 30px;\n  grid-template-columns: repeat(auto-fill,minmax(,1fr));\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid {\n  display: flex;\n  flex-flow: row wrap;\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .wf-cell,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .wf-cell {\n  flex: 1 0 ;\n  max-width: 100%;\n  padding: 15px;\n  box-sizing: border-box;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n  grid-template-columns: repeat(3,1fr);\n  grid-template-rows: auto;\n  grid-column-gap: 30px;\n  grid-row-gap: 30px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n  width: 33.333333333333%;\n  padding: 15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n  width: calc(33.333333333333%) * 2;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width:not(.centered-layout-list):not(.content-bg-on) .dt-css-grid {\n  grid-row-gap: 0px;\n}\n@media screen and (max-width: 1199px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(3,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 33.333333333333%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(33.333333333333%)*2;\n  }\n}\n@media screen and (max-width: 991px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(2,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 50%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(50%)*2;\n  }\n}\n@media screen and (max-width: 767px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(1,1fr);\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .double-width {\n    grid-column: span 1;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 100%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(100%)*2;\n  }\n}<\/style><div class=\"blog-shortcode blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 mode-grid classic-layout-list content-bg-on jquery-filter scale-img dt-css-grid-wrap dt-icon-bg-off resize-by-browser-width loading-effect-move-up description-under-image \" data-padding=\"15px\" data-cur-page=\"1\" data-post-limit=\"-1\" data-pagination-mode=\"none\" data-desktop-columns-num=\"3\" data-v-tablet-columns-num=\"2\" data-h-tablet-columns-num=\"3\" data-phone-columns-num=\"1\" data-width=\"0px\" data-columns=\"0\"><div class=\"dt-css-grid\" ><div class=\"visible wf-cell\" data-post-id=\"10839\" data-date=\"2026-07-10T17:45:02+02:00\" data-name=\"AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\"><article class=\"post project-odd visible no-img post-10839 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\" data-date=\"2026-07-10T17:45:02+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-fait-le-point-sur-son-programme-clinique-avec-larret-de-certaines-etudes-cliniques-non-prioritaires-en-vue-de-se-concentrer-sur-deux-programmes-cliniques\/\" title=\"AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\" rel=\"bookmark\">AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/07\/10\/\" title=\"17h45\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-07-10T17:45:02+02:00\">10 juillet 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 10\/07\/2026 \u2013\u00a0AB Science fait aujourd\u2019hui le point sur son programme de d\u00e9veloppement clinique et annonce l\u2019arr\u00eat de certaines \u00e9tudes clinique non prioritaires, en vue de se concentrer sur deux programmes cliniques, le programme AB8939 dans la LMA et le programme masitinib dans la SLA [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-fait-le-point-sur-son-programme-clinique-avec-larret-de-certaines-etudes-cliniques-non-prioritaires-en-vue-de-se-concentrer-sur-deux-programmes-cliniques\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science fait le point sur son programme clinique avec l\u2019arr\u00eat de certaines \u00e9tudes cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10832\" data-date=\"2026-07-08T10:43:04+02:00\" data-name=\"Le Conseil d&#039;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&#039;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\"><article class=\"post project-odd visible no-img post-10832 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\" data-date=\"2026-07-08T10:43:04+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/le-conseil-dadministration-dab-science-fait-evoluer-la-gouvernance-afin-dengager-une-nouvelle-etape-du-developpement-de-la-societe\/\" title=\"Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\" rel=\"bookmark\">Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/07\/08\/\" title=\"10h43\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-07-08T10:43:04+02:00\">8 juillet 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 08\/07\/2026 \u2013\u00a0Nomination de St\u00e9phane LEDERMANN en qualit\u00e9 de Pr\u00e9sident Directeur G\u00e9n\u00e9ral [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/le-conseil-dadministration-dab-science-fait-evoluer-la-gouvernance-afin-dengager-une-nouvelle-etape-du-developpement-de-la-societe\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Le Conseil d&rsquo;administration d\u2019AB Science fait \u00e9voluer la gouvernance afin d&rsquo;engager une nouvelle \u00e9tape du d\u00e9veloppement de la soci\u00e9t\u00e9\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10815\" data-date=\"2026-07-01T07:55:58+02:00\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\"><article class=\"post project-odd visible no-img post-10815 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\" data-date=\"2026-07-01T07:55:58+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-23-millions-deuros\/\" title=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\" rel=\"bookmark\">AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/07\/01\/\" title=\"7h55\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-07-01T07:55:58+02:00\">1 juillet 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 01\/07\/2026 \u2013 AB Science annonce aujourd&rsquo;hui le succ\u00e8s d&rsquo;une augmentation de capital d&rsquo;un montant brut total de 2,3 millions d\u2019euros souscrite par un nombre limit\u00e9 d&rsquo;investisseurs [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-23-millions-deuros\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce le succ\u00e8s d\u2019un placement prive de 2,3 millions d\u2019euros\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10790\" data-date=\"2026-06-29T07:27:17+02:00\" data-name=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\"><article class=\"post project-odd visible no-img post-10790 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\" data-date=\"2026-06-29T07:27:17+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-lachevement-de-letape-3-de-la-phase-1-evaluant-la-combinaison-dab8939-et-du-venetoclax-dans-le-traitement-de-la-lma-refractaire-ou-en-rechute\/\" title=\"AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\" rel=\"bookmark\">AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/06\/29\/\" title=\"7h27\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-29T07:27:17+02:00\">29 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 29\/06\/2026 \u2013\u00a0AB Science fait aujourd\u2019hui le point sur l\u2019\u00e9tude de phase 1 de la mol\u00e9cule AB8939 et l\u2019ach\u00e8vement de l\u2019\u00e9tape 3, \u00e9valuant la combinaison d\u2019AB8939 + v\u00e9n\u00e9toclax chez des patients atteints de leuc\u00e9mie my\u00e9lo\u00efde aigu\u00eb [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-lachevement-de-letape-3-de-la-phase-1-evaluant-la-combinaison-dab8939-et-du-venetoclax-dans-le-traitement-de-la-lma-refractaire-ou-en-rechute\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce l\u2019ach\u00e8vement de l\u2019\u00e9tape 3 de la phase 1, \u00e9valuant la combinaison d\u2019AB8939 et du v\u00e9n\u00e9toclax dans le traitement de la LMA r\u00e9fractaire ou en rechute\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10773\" data-date=\"2026-06-17T17:47:20+02:00\" data-name=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\"><article class=\"post project-odd visible no-img post-10773 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\" data-date=\"2026-06-17T17:47:20+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/le-brevet-dab-science-concernant-le-masitinib-dans-le-traitement-du-cancer-de-la-prostate-metastatique-hormono-resistant-a-ete-officiellement-delivre-aux-etats-unis-avec-une-duree-de-protecti\/\" title=\"Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\" rel=\"bookmark\">Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/06\/17\/\" title=\"17h47\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-17T17:47:20+02:00\">17 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 17\/06\/2026 \u2013\u00a0AB Science annonce aujourd\u2019hui que l\u2019Office am\u00e9ricain des brevets a officiellement d\u00e9livr\u00e9 un brevet relatif aux m\u00e9thodes de traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant (mCRPC) avec sa mol\u00e9cule phare, le masitinib [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/le-brevet-dab-science-concernant-le-masitinib-dans-le-traitement-du-cancer-de-la-prostate-metastatique-hormono-resistant-a-ete-officiellement-delivre-aux-etats-unis-avec-une-duree-de-protecti\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Le brevet d\u2019AB Science concernant le masitinib dans le traitement du cancer de la prostate m\u00e9tastatique hormono-r\u00e9sistant a \u00e9t\u00e9 officiellement d\u00e9livr\u00e9 aux Etats-Unis avec une dur\u00e9e de protection jusqu\u2019en 2042\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10746\" data-date=\"2026-06-09T18:33:53+02:00\" data-name=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&#039;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\"><article class=\"post project-odd visible no-img post-10746 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\" data-date=\"2026-06-09T18:33:53+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-presentera-lors-du-congres-annuel-2026-de-lencals-les-donnees-de-survie-issues-du-programme-clinique-du-masitinib-dans-la-sla\/\" title=\"AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\" rel=\"bookmark\">AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/06\/09\/\" title=\"18h33\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-06-09T18:33:53+02:00\">9 juin 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 09\/06\/2026 \u2013\u00a0AB Science a annonc\u00e9 aujourd&rsquo;hui que de nouvelles analyses issues de son essai de phase 3 dans la scl\u00e9rose lat\u00e9rale amyotrophique (AB10015) ont \u00e9t\u00e9 accept\u00e9es pour une pr\u00e9sentation lors de la r\u00e9union annuelle de l&rsquo;ENCALS (24-26 juin 2026, Madrid, Espagne) [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-presentera-lors-du-congres-annuel-2026-de-lencals-les-donnees-de-survie-issues-du-programme-clinique-du-masitinib-dans-la-sla\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science pr\u00e9sentera, lors du congr\u00e8s annuel 2026 de l&rsquo;ENCALS, les donn\u00e9es de survie issues du programme clinique du masitinib dans la SLA\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><\/div><!-- iso-container|iso-grid --><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css=\u00a0\u00bb.vc_custom_1601559325217{margin-top: 0px !important;padding-top: 0px !important;}\u00a0\u00bb][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3983","page","type-page","status-publish","hentry","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939<\/title>\n<meta name=\"description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Accueil\" \/>\n<meta property=\"og:description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-21T10:28:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-09-15T12:52:33+00:00\",\"dateModified\":\"2025-05-21T10:28:26+00:00\",\"description\":\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Accueil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/","og_locale":"fr_FR","og_type":"article","og_title":"Accueil","og_description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","og_url":"https:\/\/www.ab-science.com\/fr\/","og_site_name":"AB Science","article_modified_time":"2025-05-21T10:28:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2020-09-15T12:52:33+00:00","dateModified":"2025-05-21T10:28:26+00:00","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Accueil"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=3983"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3983\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=3983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}